VivoSim Labs
VIVS
114 hedge funds and large institutions have $41.8M invested in VivoSim Labs in 2018 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 35 reducing their positions, and 15 closing their positions.
0% more ownership
Funds ownership: 0.15% → 0.16% (+0%)
0% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 15
1% less funds holding
Funds holding: 115 → 114 (-1)
14% less capital invested
Capital invested by funds: $48.3M → $41.8M (-$6.55M)
23% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 35
39% less call options, than puts
Call options by funds: $37K | Put options by funds: $61K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$599K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$322K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$184K |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$114K |
| 5 |
Bank of New York Mellon
New York
|
+$112K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
-$119K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$115K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$102K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$101K |
| 5 |
Barclays
London,
United Kingdom
|
-$50.4K |
VIVS Hedge Fund Activity: Q4 2018 in Review
114 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q4 2018, worth a combined $41.8M — down 14% from $48.3M a quarter earlier.
Fund positioning in VIVS was balanced in Q4 2018: 15 funds opened new positions, 15 closed out, 27 added to existing stakes and 35 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $599K. The largest seller was Sigma Planning Corp, cutting an estimated $119K.
- 114 institutional investors held VivoSim Labs (VIVS) as of Q4 2018, down from 115 in Q3 2018.
- Funds reported $41.8M of VivoSim Labs stock for Q4 2018, down 14% quarter-over-quarter.
- 15 funds opened new VivoSim Labs positions in Q4 2018 and 15 closed out, a net change of 0 holders.
- The largest VivoSim Labs buyer in Q4 2018 was Renaissance Technologies, an estimated $599K added.
- The largest VivoSim Labs seller in Q4 2018 was Sigma Planning Corp, an estimated $119K sold.
Based on aggregated 13F filings for Q4 2018.